D
Daniel Sellers
Researcher at Beth Israel Deaconess Medical Center
Publications - 9
Citations - 368
Daniel Sellers is an academic researcher from Beth Israel Deaconess Medical Center. The author has contributed to research in topics: Biology & Neutralizing antibody. The author has an hindex of 3, co-authored 9 publications receiving 93 citations.
Papers
More filters
Journal ArticleDOI
Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women.
Ai-ris Y. Collier,Ai-ris Y. Collier,Katherine McMahan,Jingyou Yu,Lisa H. Tostanoski,Ricardo Aguayo,Jessica L Ansel,Abishek Chandrashekar,Shivani A. Patel,Esther A. Bondzie,Daniel Sellers,Julia Barrett,Owen Sanborn,Huahua Wan,Aiquan Chang,Aiquan Chang,Tochi Anioke,Joseph P. Nkolola,Connor Bradshaw,Catherine Jacob-Dolan,Catherine Jacob-Dolan,Jared Feldman,Jared Feldman,Makda S. Gebre,Makda S. Gebre,Erica N. Borducchi,Jinyan Liu,Aaron G. Schmidt,Aaron G. Schmidt,Todd J. Suscovich,Caitlyn Linde,Galit Alter,Galit Alter,Michele R. Hacker,Michele R. Hacker,Dan H. Barouch +35 more
TL;DR: In this article, the authors evaluated the immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women, including against emerging SARS-CoV-2 variants of concern.
Journal ArticleDOI
Optimization of Non-Coding Regions for a Non-Modified mRNA COVID-19 Vaccine.
Makda S. Gebre,Susanne Rauch,Nicole Roth,Jingyou Yu,Abishek Chandrashekar,Noe B. Mercado,Xuan He,Jinyan Liu,Katherine McMahan,Amanda J. Martinot,David R. Martinez,Tori Giffin,David L. Hope,Shivani A. Patel,Daniel Sellers,Owen Sanborn,Julia Barrett,Xiaowen Liu,Andrew C. Cole,Laurent Pessaint,Daniel Valentin,Zack Flinchbaugh,Jake Yalley-Ogunro,Jeanne Muench,Renita Brown,Anthony L. Cook,Elyse Teow,Hanne Leth Andersen,Mark G. Lewis,Adrianus C. M. Boon,Ralph S. Baric,Stefan O. Mueller,Benjamin Petsch,Dan H. Barouch,Dan H. Barouch +34 more
TL;DR: In this paper, a head-to-head study of the immunogenicity and protective efficacy of CVnCoV and CV2CoV in nonhuman primates was conducted.
Journal ArticleDOI
Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.
Jingyou Yu,Lisa H. Tostanoski,Noe B. Mercado,Katherine McMahan,Jinyan Liu,Catherine Jacob-Dolan,Catherine Jacob-Dolan,Abishek Chandrashekar,Caroline Atyeo,Caroline Atyeo,David R. Martinez,Tochi Anioke,Esther A. Bondzie,Aiquan Chang,Aiquan Chang,Sarah Gardner,Victoria M. Giffin,David L. Hope,Felix Nampanya,Joseph P. Nkolola,Shivani A. Patel,Owen Sanborn,Daniel Sellers,Huahua Wan,Tammy Hayes,Katherine Bauer,Laurent Pessaint,Daniel Valentin,Zack Flinchbaugh,Renita Brown,Anthony L. Cook,Deandre Bueno-Wilkerson,Elyse Teow,Hanne Leth Andersen,Mark G. Lewis,Amanda J. Martinot,Ralph S. Baric,Galit Alter,Frank Wegmann,Roland Zahn,Hanneke Schuitemaker,Dan H. Barouch,Dan H. Barouch,Dan H. Barouch +43 more
TL;DR: Ad26.COV2.S as discussed by the authors elicits humoral and cellular immune responses that cross-react with the B.1.351 challenge in rhesus macaques.
Posted ContentDOI
Immune Responses in Fully Vaccinated Individuals Following Breakthrough Infection with the SARS-CoV-2 Delta Variant in Provincetown, Massachusetts
Ai-ris Y. Collier,Ai-ris Y. Collier,Catherine M. Brown,Katherine McMahan,Jingyou Yu,Jinyan Liu,Catherine Jacob-Dolan,Catherine Jacob-Dolan,Abishek Chandrashekar,Dylan Tierney,Jessica L Ansel,Marjorie Rowe,Daniel Sellers,Kunza Ahmad,Ricardo Aguayo,Tochi Anioke,Sarah Gardner,Mazuba Siamatu,Lorraine Bermudez Rivera,Michele R. Hacker,Michele R. Hacker,Lawrence C. Madoff,Dan H. Barouch,Dan H. Barouch,Dan H. Barouch +24 more
TL;DR: In this article, Humoral and cellular immune responses were assessed in 35 vaccinated individuals who were tested for SARS-CoV-2 in the Massachusetts Department of Public Health outbreak investigation.
Journal ArticleDOI
Prior infection with SARS-CoV-2 WA1/2020 partially protects rhesus macaques against re-infection with B.1.1.7 and B.1.351 variants.
Abishek Chandrashekar,Jinyan Liu,Jingyou Yu,Katherine McMahan,Lisa H. Tostanoski,Catherine Jacob-Dolan,Catherine Jacob-Dolan,Noe B. Mercado,Tochi Anioke,Aiquan Chang,Aiquan Chang,Sarah Gardner,Victoria M. Giffin,David L. Hope,Felix Nampanya,Shivani A. Patel,Owen Sanborn,Daniel Sellers,Huahua Wan,Amanda J. Martinot,John J. Baczenas,Shelby L. O’Connor,Laurent Pessaint,Daniel Valentin,Benjamin Espina,Lauren Wattay,Maria Grazia Ferrari,Renita Brown,Anthony L. Cook,Deandre Bueno-Wilkerson,Elyse Teow,Hanne Leth Andersen,Mark G. Lewis,Dan H. Barouch,Dan H. Barouch,Dan H. Barouch +35 more
TL;DR: In this paper, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants that result in increased transmissibility and partial evasion of neutralizing antibodies have recently emerged.